JCU CORPORATION FY2027 Q1 Earnings Report

Quick View

Executive Summary

Revenue, led by the core Chemical Business, maintained its trend of year-on-year increases for the sixth consecutive period; however, operating income declined because the increase in SG&A expenses exceeded revenue growth, resulting in higher revenue but lower operating profit. Revenue was ¥74.9B (+6.5% YoY), operating income was ¥27.4B (△2.3%), ordinary income was ¥29.1B (+2.2%), and net income (net income attributable to owners of the parent, equal to consolidated net income) was ¥20.8B (+2.5%). Although the increase in SG&A expenses pressured profit at the operating level, non-operating income, including foreign exchange gains, provided support, enabling modest increases in ordinary income and net income.

Factors Affecting Results

【Revenue】Revenue increased 6.5% YoY to ¥74.9B. By segment, Chemical led the increase, generating ¥70.6B (+18.2% YoY) and accounting for 94.2% of total company revenue, while Equipment declined significantly to ¥4.3B (△59.2%), restraining the overall increase in revenue.

【Profit and Loss】Operating income declined 2.3% YoY to ¥27.4B. The gross margin improved by +1.1pt from the previous year to 69.0%; however, the SG&A expense ratio rose +4.5pt to 32.5%, causing the operating margin to decline to 36.5% (△3.3pt YoY). The primary causes of the increase in SG&A expenses appear to have been higher fixed costs, including salaries and allowances and depreciation, while underabsorption of fixed costs associated with the sharp decline in Equipment revenue may also have pressured the company-wide margin. Meanwhile, ordinary income increased 2.2% YoY to ¥29.1B and net income increased 2.5% to ¥20.8B, as non-operating income of ¥1.8B, including a foreign exchange gain of ¥1.2B, offset the decline in operating income. Extraordinary income was limited to extraordinary gains of ¥0.02B and was immaterial; therefore, it was not a factor behind the divergence between ordinary income and net income. In summary, operating income declined, but the contribution from non-operating income resulted in higher revenue and net income at the final stage.

Segment Analysis

The Chemical Business recorded revenue of ¥70.6B (+18.2% YoY), operating income of ¥29.4B (+3.4%), and a profit margin of 41.6%, maintaining high profitability and generating the majority of company-wide operating income. The Equipment Business contracted substantially, with revenue of ¥4.3B (△59.2%), operating income of ¥0.6B (△72.1%), and a profit margin of 13.1%, directly contributing to the decline in company-wide operating income. The gap in profit margins between the two segments is substantial, and the earnings structure remains highly dependent on Chemical. Company-wide expenses (adjustments) were △¥2.6B, almost unchanged from △¥2.5B in the previous year, indicating that fluctuations in segment profitability were the primary cause of the decline in operating income.

Key Financial Metrics

【Profitability】The operating margin was 36.5% (△3.3pt from approximately 36.5% in the previous year), while the net profit margin was 27.7%. The increase in the SG&A expense ratio to 32.5% (+4.5pt YoY) exceeded the improvement in the gross margin to 69.0% (+1.1pt), resulting in a contraction in operating-level margins. 【Cash Flow Quality】Trade receivables (notes and accounts receivable) were ¥81.2B and inventories were ¥22.4B, both remaining almost flat from the previous year. Meanwhile, accounts payable declined significantly to ¥10.4B from ¥20.3B in the previous year, suggesting that the reduction in trade payables may have absorbed cash through working capital. 【Investment Efficiency】ROE was 3.7% (quarterly result). Under DuPont analysis, it comprised a net profit margin of 27.7%, total asset turnover of 0.124x, and financial leverage of 1.08x, indicating that profitability is the primary earnings driver. EPS was ¥84.29 (¥81.25 in the previous year, YoY +3.7%). 【Financial Soundness】The equity ratio rose to 92.5% from 87.1% in the previous year, while cash and deposits of ¥222.7B accounted for 36.7% of total assets, indicating that the company maintains an extremely conservative financial structure.

Cash Flow Analysis

As no cash flow statement has been disclosed, cash flow trends are analyzed based on changes in the balance sheet. Cash and deposits were ¥222.7B, down from ¥242.3B in the previous year, and the significant decline in accounts payable to ¥10.4B from ¥20.3B is believed to have been a cash outflow factor through the reduction in trade payables. Meanwhile, construction in progress declined substantially to ¥10.3B from ¥55.9B, while machinery, equipment, and vehicles increased to ¥35.7B from ¥10.1B, suggesting that investment projects were completed and transferred to operating assets. Land also increased to ¥29.9B from ¥21.5B, indicating potential for additional capital investment. Net assets increased to ¥560.9B from ¥545.7B in the previous year, supported by the accumulation of retained earnings as well as increases in foreign currency translation adjustments and valuation difference on available-for-sale securities. Cash on hand remains ample, securing financial capacity for both investment and shareholder returns.

Earnings Quality

The majority of current-period profit was derived from recurring income based on operating activities, while extraordinary gains were only ¥0.02B and had little temporary impact on net income. Foreign exchange gains accounted for ¥1.2B of non-operating income of ¥1.8B. Although this represented only approximately 1.6% of revenue, the gain contributed to the increase in ordinary income by offsetting the decline in operating income. As foreign exchange gains are subject to fluctuations in foreign exchange rates, their recurrence is limited and this should be noted. The difference between ordinary income of ¥29.1B and net income of ¥20.8B was attributable to income taxes of ¥8.3B. The effective tax rate was approximately 28.6%, a standard level, with no unusual factors identified in the tax burden. Comprehensive income was ¥28.5B, ¥7.7B higher than net income of ¥20.8B. The primary causes of the difference were foreign currency translation adjustments of +¥4.5B and valuation difference on available-for-sale securities of +¥3.2B, indicating that valuation-related non-operating items boosted comprehensive income.

Earnings Forecast and Guidance

The Q1 progress rates against the full-year earnings forecasts were 22.4% for revenue (¥74.9B/¥334.0B), 22.3% for operating income (¥27.4B/¥123.0B), 23.3% for ordinary income (¥29.1B/¥125.0B), and 23.6% for net income (¥20.8B/¥88.0B). Compared with the simple benchmark of 25% for equal progress across four quarters, all metrics were slightly below this level, with the deviations in revenue and operating income being relatively large. The sharp decline in Equipment revenue and the front-loaded increase in SG&A expenses appear to have been factors. Achievement of the full-year plan is therefore expected to depend on a recovery in the business during the second half and expense control. There were no revisions to the earnings or dividend forecasts during the quarter.

Shareholder Returns

The full-year dividend forecast is ¥180 per share, implying a payout ratio of approximately 50.4% against full-year forecast EPS of ¥357.44. Compared with the previous year's actual dividend of ¥41 (the actual amount combining interim and year-end dividends, etc.), the company is moving toward a dividend increase. Against forecast full-year net income of ¥88.0B, the total dividend amount (estimated based on approximately 24.62 million effective shares outstanding) is at a level sufficiently covered by earnings. Given the substantial cash and deposits of ¥222.7B and the strong financial position reflected by an equity ratio of 92.5%, there is currently no need for monitoring from the perspective of securing funds for dividends.

Risk Factors

1. Segment concentration risk: Chemical accounts for 94.2% of revenue (¥70.6B/¥74.9B), and the business portfolio is highly dependent on demand trends in Chemical.

2. Slowdown in the Equipment Business: Revenue declined to ¥4.3B (△59.2% YoY) and operating income to ¥0.6B (△72.1%), making it the primary cause of the decline in the company-wide operating margin through underabsorption of fixed costs.

3. Continued cost increases: The SG&A expense ratio rose to 32.5% (+4.5pt YoY). If expense growth exceeding revenue growth (+6.5%) continues, it could place further pressure on the operating margin.

Industry Benchmark (For Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

Both the operating margin and net profit margin are substantially above the industry median, indicating a high level of profitability within the industry.

Growth and Capital Efficiency

The revenue growth rate is approximately in line with the industry median, indicating an industry-average pace of growth.

※Source: Compiled by the company

Key Takeaways from the Results

1. The profit margin of the core Chemical Business remained high at 41.6% and continues to serve as the center of company-wide profitability. Meanwhile, the sharp slowdown in Equipment was the primary cause of the decline in operating income. The widening performance gap between the segments is an important point for monitoring the earnings structure.

2. The SG&A expense ratio rose +4.5pt YoY, and the increase in expenses exceeding the improvement in the gross margin pressured the operating margin. Future trends in expense control are expected to determine the direction of margin trends.

3. The strong financial position, reflected in an equity ratio of 92.5% and cash and deposits of ¥222.7B, indicates resilience to changes in the business environment. Financial capacity remains secured even though full-year progress is slightly below plan.

Theoretical Share Price (Reference Value)

This is a mechanically calculated reference range based solely on publicly disclosed data using a residual income model (Ohlson-type model with an explicit 5-year fade). It is not a forecast of the market share price or a recommendation to take any specific investment action.

Sensitivity: ¥2,670–¥2,823 at ±1% for the cost of equity, and ¥2,734–¥2,761 at ±0.1 for ω.

Notes:

• Net assets as of the end of the quarter are used (there is a timing difference relative to the full-year forecast).
• As net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual income model / Interest rate reference month: 2026-07 / This value does not predict or guarantee the future share price)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting with a professional adviser as necessary.

---End of Report---